Effect of skeletal muscle Na+ channel delivered via a cell platform on cardiac conduction and arrhythmia induction

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 4, 2012, Pages 831-840

  Boink, Gerard J J ^a,b,c   Lu, Jia ^d   Driessen, Helen E ^a   Duan, Lian ^a   Sosunov, Eugene A ^a   Anyukhovsky, Evgeny P ^a   Shlapakova, Iryna N ^a   Lau, David H ^a   Rosen, Tove S ^a   Danilo, Peter ^a   Jia, Zhiheng ^d   Ozgen, Nazira ^a   Bobkov, Yevgeniy ^a   Guo, Yuanjian ^d   Brink, Peter R ^d   Kryukova, Yelena ^a   Robinson, Richard B ^a   Entcheva, Emilia ^e   Cohen, Ira S ^a   Rosen, Michael R ^a,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d STONY BROOK UNIVERSITY   (United States)

^e St Francis Hospital The Heart Center   (United States)

Author keywords

Arrhythmia; Cardiac conduction; Cell therapy; Gene therapy; Myocardial infarction; Na+ channels

Indexed keywords

ADENOVIRUS VECTOR; SKELETAL MUSCLE SODIUM CHANNEL; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; EPICARDIUM; GENE THERAPY; GENETIC TRANSFECTION; HEART CONDUCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; QRS COMPLEX; VIRAL GENE DELIVERY SYSTEM;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; CARDIAC PACING, ARTIFICIAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOGS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SODIUM CHANNELS; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TRANSFECTION; VENTRICULAR FIBRILLATION;

EID: 84867150744     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.969907     Document Type: Article

References (45)

1. Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001;103:769-777. (Pubitemid 32144209)
2. Wit AL, Janse MJ. Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction. Circulation. 1992;85(1 Suppl):I32-I42.
3. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev. 1989;69:1049-1169. (Pubitemid 19255835)
4. Lau DH, Clausen C, Sosunov EA, Shlapakova IN, Anyukhovsky EP, Danilo P Jr, Rosen TS, Kelly C, Duffy HS, Szabolcs MJ, Chen M, Robinson RB, Lu J, Kumari S, Cohen IS, Rosen MR. Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study. Circulation. 2009;119:19-27.
5. Anyukhovsky EP, Sosunov EA, Kryukova YN, Prestia K, Ozgen N, Rivaud M, Cohen IS, Robinson RB, Rosen MR. Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart. Cardiovasc Res. 2011;89:41-50.
6. Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, Robinson RB, Rosen MR, Brink PR, Cohen IS. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol (Lond). 2004;555(Pt 3):617-626. (Pubitemid 38404584)
7. Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P Jr, Lorell BH, Potapova IA, Lu Z, Rosen AB, Mathias RT, Brink PR, Robinson RB, Cohen IS, Rosen MR. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-713. (Pubitemid 47255987)
8. Lu J, Wang HZ, Jia Z, Zuckerman J, Lu Z, Guo Y, Boink GJ, Brink PR, Robinson RB, Entcheva E, Cohen IS. Improving cardiac conduction with a skeletal muscle sodium channel by gene and cell therapy. J Cardiovasc Pharmacol. 2012;60:88-99. April 20, 2012. [Epub ahead of print] doi:10.1097/FJC. 0b013e3182588b00.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147. (Pubitemid 29282067)
10. Mathias RT, Cohen IS, Oliva C. Limitations of the whole cell patch clamp technique in the control of intracellular concentrations. Biophys J. 1990;58:759-770. (Pubitemid 20312932)
11. Bien H, Yin L, Entcheva E. Calcium instabilities in mammalian cardiomyocyte networks. Biophys J. 2006;90:2628-2640.
12. Entcheva E, Bien H. Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution. Prog Biophys Mol Biol. 2006;92:232-257.
13. le Marec H, Dangman KH, Danilo P Jr, Rosen MR. An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction. Circulation. 1985;71:1224-1236. (Pubitemid 15036370)
14. Ly HQ, Nattel S. Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation. 2009;119:1824-1831.
15. Macia E, Boyden PA. Stem cell therapy is proarrhythmic. Circulation. 2009;119:1814-1823.
16. Mines GR. On dynamic equilibrium in the heart. J Physiol (Lond). 1913;46:349-383.
17. Mines GR. On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. Trans R Soc Can. 1913;46: 349-383.
18. Hennan JK, Swillo RE, Morgan GA, Keith JC Jr, Schaub RG, Smith RP, Feldman HS, Haugan K, Kantrowitz J, Wang PJ, Abu-Qare A, Butera J, Larsen BD, Crandall DL. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J Pharmacol Exp Ther. 2006;317:236-243.
19. Boink GJ, Rosen MR. Regenerative therapies in electrophysiology and pacing: introducing the next steps. J Interv Card Electrophysiol. 2011;31:3-16.
20. Macia E, Dolmatova E, Cabo C, Sosinsky AZ, Dun W, Coromilas J, Ciaccio EJ, Boyden PA, Wit AL, Duffy HS. Characterization of gap junction remodeling in epicardial border zone of healing canine infarcts and electrophysiological effects of partial reversal by rotigaptide. Circ Arrhythm Electrophysiol. 2011;4:344-351.
21. Wiegerinck RF, de Bakker JM, Opthof T, de Jonge N, Kirkels H, Wilms-Schopman FJ, Coronel R. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure. Basic Res Cardiol. 2009;104:321-332.
22. Feld Y, Melamed-Frank M, Kehat I, Tal D, Marom S, Gepstein L. Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation. 2002;105:522-529. (Pubitemid 34141712)
23. Yankelson L, Feld Y, Bressler-Stramer T, Itzhaki I, Huber I, Gepstein A, Aronson D, Marom S, Gepstein L. Cell therapy for modification of the myocardial electrophysiological substrate. Circulation. 2008;117:720-731. (Pubitemid 351640673)
24. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006;12:1256-1258. (Pubitemid 44706927)
25. Amit G, Kikuchi K, Greener ID, Yang L, Novack V, Donahue JK. Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation. 2010;121:2263-2270.
26. Lue WM, Boyden PA. Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in Vmax and the transient outward current. Circulation. 1992;85:1175-1188.
27. Ursell PC, Gardner PI, Albala A, Fenoglio JJ Jr, Wit AL. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res. 1985;56:436-451. (Pubitemid 15119520)
28. Pu J, Boyden PA. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res. 1997;81:110-119. (Pubitemid 27272989)
29. Protas L, Dun W, Jia Z, Lu J, Bucchi A, Kumari S, Chen M, Cohen IS, Rosen MR, Entcheva E, Robinson RB. Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc Res. 2009;81:528-535.
30. Potapova I, Plotnikov A, Lu Z, Danilo P Jr, Valiunas V, Qu J, Doronin S, Zuckerman J, Shlapakova IN, Gao J, Pan Z, Herron AJ, Robinson RB, Brink PR, Rosen MR, Cohen IS. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res. 2004;94: 952-959. (Pubitemid 38490073)
31. Valiunas V, Kanaporis G, Valiuniene L, Gordon C, Wang HZ, Li L, Robinson RB, Rosen MR, Cohen IS, Brink PR. Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit. J Physiol (Lond). 2009;587(Pt 21):5211-5226.
32. Penkoske PA, Sobel BE, Corr PB. Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation. 1978;58:1023-1035. (Pubitemid 9091985)
33. Garlick PB, Radda GK, Seeley PJ. Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance. Biochem J. 1979;184:547-554. (Pubitemid 10183589)
34. Coronel R, Lau DH, Sosunov EA, Janse MJ, Danilo P Jr, Anyukhovsky EP, Wilms-Schopman FJ, Opthof T, Shlapakova IN, Ozgen N, Prestia K, Kryukova Y, Cohen IS, Robinson RB, Rosen MR. Cardiac expression of skeletal muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarction. Heart Rhythm. 2010;7:1104-1110.
35. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474-11479. (Pubitemid 41153844)
36. Gyöngyösi M, Blanco J, Marian T, Trón L, Petneházy O, Petrasi Z, Hemetsberger R, Rodriguez J, Font G, Pavo IJ, Kertész I, Balkay L, Pavo N, Posa A, Emri M, Galuska L, Kraitchman DL, Wojta J, Huber K, Glogar D. Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging. 2008;1:94-103.
37. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923-940.
38. Chang MG, Tung L, Sekar RB, Chang CY, Cysyk J, Dong P, Marbán E, Abraham MR. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation. 2006;113:1832-1841. (Pubitemid 43739394)
39. Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar RR. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol. 2006;111:231-239. (Pubitemid 44107562)
40. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92-95. (Pubitemid 38813459)
41. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res. 2011;108:792-796.
42. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277-2286.
43. Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 2011;9:97-102.
44. Jeong JO, Han JW, Kim JM, Cho HJ, Park C, Lee N, Kim DW, Yoon YS. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res. 2011;108:1340-1347.
45. Rosen AB, Kelly DJ, Schuldt AJ, Lu J, Potapova IA, Doronin SV, Robichaud KJ, Robinson RB, Rosen MR, Brink PR, Gaudette GR, Cohen IS. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells. 2007;25: 2128-2138. (Pubitemid 47258192)